Dr. Seema Nagpal, MD
Claim this profileStanford Cancer Institute
Studies Glioblastoma
Studies Solid Tumors
10 reported clinical trials
13 drugs studied
Area of expertise
1Glioblastoma
Stage II
Stage I
2Solid Tumors
Stage IV
BRAF positive
Stage III
Affiliated Hospitals
Clinical Trials Seema Nagpal, MD is currently running
BPM31510 + Vitamin K1
for Glioblastoma
This is a single-arm, non-randomized, open-label Phase 2 therapeutic study that will assess the effects of adding BPM31510 onto a conventional treatment framework of RT and concurrent TMZ chemotherapy for subjects with newly diagnosed glioblastoma.
Recruiting1 award Phase 29 criteria
QBS72S
for Brain Cancer from Breast Cancer
This trial is testing a new drug called QBS72S for people with advanced breast cancer that has spread to the brain. The goal is to see if this drug can shrink brain tumors and help patients live longer. Researchers are also checking if the drug is safe for these patients.
Recruiting1 award Phase 2
More about Seema Nagpal, MD
Clinical Trial Related2 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Seema Nagpal, MD has experience with
- Optune®
- ABM-1310
- Cobimetinib
- BPM31510
- Bevacizumab
- NovoTTF-200A Device
Breakdown of trials Seema Nagpal, MD has run
Glioblastoma
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Seema Nagpal, MD specialize in?
Seema Nagpal, MD focuses on Glioblastoma and Solid Tumors. In particular, much of their work with Glioblastoma has involved Stage II patients, or patients who are Stage I.
Is Seema Nagpal, MD currently recruiting for clinical trials?
Yes, Seema Nagpal, MD is currently recruiting for 4 clinical trials in Stanford California. If you're interested in participating, you should apply.
Are there any treatments that Seema Nagpal, MD has studied deeply?
Yes, Seema Nagpal, MD has studied treatments such as Optune®, ABM-1310, Cobimetinib.
What is the best way to schedule an appointment with Seema Nagpal, MD?
Apply for one of the trials that Seema Nagpal, MD is conducting.
What is the office address of Seema Nagpal, MD?
The office of Seema Nagpal, MD is located at: Stanford Cancer Institute, Stanford, California 94305 United States. This is the address for their practice at the Stanford Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.